N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line

Cancer Research

Volumn 59, Issue 12, 1999, Pages 2898-2902

  Chambéry, Daniel ^a   Mohseni Zadeh, Sarah ^a   De Gallé, Brigitte ^a   Babajko, Sylvie ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; DNA SYNTHESIS; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MOUSE; NEUROBLASTOMA; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; CELL DIVISION; DNA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MICE; MICE, NUDE; NEUROBLASTOMA; PROMOTER REGIONS (GENETICS); RECEPTOR, IGF TYPE 1; SOMATOMEDINS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0345711633     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Jones, J. I., and Clemmons, D. R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev., 16: 3-34, 1995.
2. Feldman, E. L., Sullivan, K. A., Kim, B., and Russell, J. W. Insulin-like growth factors regulate neuronal differentiation and survival. Neurobiol. Dis., 4: 201-214, 1997.
3. Werner, H., and LeRoith, D. The role of the insulin-like growth factor system in human cancer. Adv. Cancer Res., 68: 183-222, 1996.
4. LeRoith, D., Werner, H., Beitner-Johnson, D., and Roberts, C. T. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev., 16: 143-163, 1996.
5. De Meyts, P., Wallach, B., Christoffersen, C. T., Urso, B., Gronskov, K., Latus, L. J., Yakushiji, F., Ilondo, M. M., and Shymko, R. M. The insulin-like growth factor-I receptor. Horm. Res. (Basel), 42: 152-169, 1994.
6. Baserga, R., Hongo, A., Rubini, M., Prisco, M., and Valentinis, B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta Rev. Cancer, 1332: F105-F126, 1997.
7. O'Connor, R., Kauffmann-Zeh, A., Liu, Y., Lehar, S., Evan, G. I., Baserga, R., and Blättler, W. A. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol. Cell. Biol., 17: 427-435, 1997.
8. Hongo, A., Yumet, G., Resnicoff, M., Romano, G., O'Connor, R., and Baserga, R. Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor. Cancer Res., 58: 2477-2484, 1998.
9. Liu, X., Turbyville, T., Fritz, A., and Whitesell, L. Inhibition of insulin-like growth factor 1 receptor expression in neuroblastoma cells induces the regression of established tumors in mice. Cancer Res., 58: 5432-5438, 1998.
10. Ellis, M. J., Leav, B. A., Yang, Z., Rasmussen, A., Pearce, A., Zweibel, J., Lippman, M. E., and Cullen, K. J. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol. Endocrinol., 10: 286-297, 1996.
11. Castleberry, R. P. Neuroblastoma. Eur. J. Cancer, 33: 1430-1438, 1997.
12. Caron, H., van Sluis, P., and de Kraker, J. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N. Engl. J. Med., 334: 225-230, 1996.
13. Ambros, I. M., Zellner, A., Roald, B., Amann, G., Ladenstein, R., Printz, D., Gadner, H., and Ambros, P. F. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N. Engl. J. Med., 334: 1505-1539, 1996.
14. Schwab, M., Alitalo, K., Klempnauer, K. H., Varmus, H. E., Bishop, J. M., Gilbert, F., Brodeur, G. M., Golstein, M., and Trent, J. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature (Lond.), 305: 245-248, 1983.
15. Brodeur, G. M., and Nakagawara, A. Molecular basis of clinical heterogeneity in neuroblastoma. Am. J. Pediatr. Hematol. Oncol., 14: 111-116, 1992.
16. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Sergel, S. E., Wong, K. Y., and Hammond, D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma. N. Engl. J. Med., 313: 1111-1116, 1985.
17. Weiss, W. A., Aldage, K., Mohapatra, G., Feuerstein, B. G., and Bishop, J. M. Targeted expression of N-myc causes neuroblastoma in transgenic mice. EMBO J., 16: 2985-2995, 1997.
18. El-Badry, O. M., Helman, L. J., Chatten, J., Steinberg, S. M., Evans, A. E., and Israel, M. A. Insulin-like growth factor II-mediated proliferation of human neuroblasloma. J. Clin. Investig., 87: 648-657, 1991.
19. Babajko, S., Leneuve, P., Loret, C., and Binoux, M. IGFBP-6 is involved in growth inhibition in SH-SY5Y human neuroblastoma cells. Its production is both IGF- and cell density-dependent. J. Endocrinol., 152: 221-227, 1997.
20. Menouny, M., Binoux, M., and Babajko, S. Role of IGFBP-2 and its limited proteolysis in neuroblastoma cell proliferation. Modulation by TGF-β and retinoic acid. Endocrinology, 136: 683-690, 1997.
21. Shimasaki, S., and Ling, N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog. Growth Factor Res., 3: 243-266, 1991.
22. Grellier, P., de Gallé, B., and Babajko, S. Expression of insulin-like growth factor binding protein 6 complementary DNA alters neuroblastoma cell growth. Cancer Res., 58: 1670-1676, 1998.
23. Singh, P., Dai, B., Dhruva, B., and Widen, S. G. Episomal expression of sense and antisense insulin-like growth factor (IGF)-binding protein-4 complementary DNA alters the mitogenic response of a human colon cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-1. Cancer Res., 54: 6563-6570, 1994.
24. Sadee, W., Yu, V. C., Richards, M. L., Preis, P. N., Schwab, M. R., Brodsky, F. M., and Biedler, J. L. Expression of neurotransmitter receptors and myc proto-oncogenes in subclones of a human neuroblastoma cell line. Cancer Res., 47: 5207-5212, 1987.
25. Biedler, J. L., Helson, L., and Spengler, B. A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res., 33: 2643-2652, 1973.
26. Babajko, S., and Binoux, M. Modulation by retinoic acid of insulin-like growth factor (IGF) and IGF binding protein expression in human neuroblastoma cells. Eur. J. Endocrinol., 134: 474-480, 1996.
27. Babajko, S., Tronche, F., and Groyer, A. Liver-specific expression of human insulin-like growth factor binding protein 1: functional role of transcription factor HNF1 in vivo. Proc. Natl. Acad. Sci. USA, 90: 272-276, 1993.
28. Maniatis, T., Fritsch, E. F., and Sambrook, J. Extraction, purification and analysis of mRNA from eukaryotic cells. In: Molecular Cloning: A Laboratory Manual, pp. 188-209. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
29. Singleton, J. R., Randolph, A. E., and Feldman, E. L. Insulin-like growth factor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res., 56: 4522-4529, 1996.
30. Sumantran, V. N., and Feldman, E. L. Insulin-like growth factor receplor-I regulates c-myc and GAP-43 messenger ribonucleic acid expression in SH-SY5Y human neuroblastoma cells. Endocrinology, 132: 2017-2023, 1993.
31. Hopewell, R., Li, L., MacGregor, D., Nerlov, C., and Ziff, E. B. Regulation of cell proliferation and differentiation by myc. J. Cell Sci., 19: 85-89, 1995.
32. Lüscher, B., and Eisenman, R. N. New light on Myc and Myb. Part I: Myc. Genes Dev., 4: 2025-2035, 1990.
33. 1, integrin submit. Oncogene, 12: 2599-2607, 1995.
34. 1 integrin in human neuroblastoma: relationships to disease progression in a nude mouse model system. Clin. Exp. Metastasis, 2: 123-133, 1995.
35. Wang, H. P., Zhang, L., Dandri, M., and Rogler, C. E. Antisense down-regulation of N-mycl in woodchuck hepatoma cells reverses the malignant phenotype. J. Virol., 3: 2192-2198, 1998.
36. Cooke, D. W., Bankert, L. A., Roberts, C. T., Jr., LeRoith, D., and Casella, S. J. Analysis of the human type I insulin-like growth factor receptor promoter region. Biochem. Biophys. Res. Commun., 177: 1113-1120, 1991.
37. Rubini, M., Werner, H., Gandini, E., Roberts, C. T., Jr., LeRoith, D., and Baserga, R. Plateted-derived growth factor increases the activity of the promoter of the IGF-I receptor gene. Exp. Cell. Res., 211: 374-379, 1994.
38. Moreno, B., Rodriguez-Manzaneque, J. C., Perez-Castillo, A., and Santos, A. Thyroid hormone controls the expression of insulin-like growth factor I receptor gene at different levels in lung and heart of developing and adult rats. Endocrinology, 3: 1194-1203, 1997.
39. Lou, H., Ramwell, P. W., and Foegh, M. L. Estradiol 17-β represses insulin-like growth factor I receptor expression in smooth muscle cells from rabbit cardiac recipients. Transplantation (Baltimore), 4: 419-426, 1998.
40. Hernandez-Sanchez, C., Werner, H., Roberts, C. T., Jr., Woo, E. J., Hum, D. W., Rosenthal, S. M., and LeRoith, D. Differential regulation of insulin-like growth factor I (IGF-1) receptor gene expression by IGF-1 and basic fibroblastic growth factor. J. Biol. Chem., 272: 4663-4670, 1997.
41. Prisco, M., Hongo, A., Rizzo, M. G., Sacchi, A., and Baserga, R. The insulin-like growth factor 1 receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol. Cell. Biol., 17: 1084-1092, 1997.
42. Werner, H., Re, G. G., Drummond, I. A., Sukhatme, V. P., and Rauscher, F. J., III, Sens, D. A., Garvin, A. J., and LeRoith, D. Increased expression of the insulin-like growth factor-1 receptor gene, IGF-1R, in Wilms tumor is correlated with modulation of IGF-1R promoter activity by the WT1 Wilms tumor gene product. Proc. Natl. Acad. Sci. USA, 12: 5828-5832, 1993.
43. 1. Oncogene, 14: 1341-1350, 1997.
44. El-Badry, O. M., Romanus, J. A., Helman, L. J., Cooper, M. J., Rechler, M. M., and Israel, M. A. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J. Clin. Investig., 84: 829-839, 1989.
45. Lalou, C., Lassarre, C., and Binoux, M. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology, 8: 3206-3212, 1996.
46. Baserga, R. The insulin-like growth factor receptor: a key to tumor growth? Cancer Res., 55: 249-252, 1995.